Share this article
CEDAR KNOLLS, N.J., Dec. 15, 2020 /PRNewswire/
MYOS CORP ( MYOS or the Company ), is a research-based advanced nutrition company with divisions that address both
Human Nutrition and
Fortetropin
®, a proprietary advanced nutrition product developed and owned by MYOS, that has been shown in multiple veterinary and human clinical studies to accelerate gains in muscle mass, improve mobility and enhance recovery from injury.
On November 17, 2020, Nasdaq-listed Myos Rens Technology, Inc. ( MYOS RENS ) consummated the previously announced merger of its wholly owned subsidiary with and into MedAvail, Inc., a privately held Delaware corporation (the Merger ), after which MYOS RENS was renamed MedAvail Holdings, Inc. ( MedAvail ) and the stock symbol of the company was changed to MDVL.